-+ 0.00%
-+ 0.00%
-+ 0.00%

Vir Biotechnology Grants Norgine Exclusive License for Hepatitis Delta Treatment in Europe, Australia, and New Zealand

Reuters·12/16/2025 21:06:01

Please log in to view news